BRCA1 Promoter Methylation Status in 1031 Primary Breast Cancers Predicts Favorable Outcomes Following Chemotherapy

BACKGROUND: Breast Cancer 1 gene (BRCA1) is known to be inactivated in breast tumors by promoter methylation. Tumor cells in patients carrying a germline mutation in BRCA1 are sensitive to cytotoxic drugs that cause DNA double strand breaks. However, very little is known on whether patients with BRC...

Descripción completa

Detalles Bibliográficos
Autores principales: Stefansson, Olafur A, Hilmarsdottir, Holmfridur, Olafsdottir, Kristrun, Tryggvadottir, Laufey, Sverrisdottir, Asgerdur, Johannsson, Oskar T, Jonasson, Jon G, Eyfjord, Jorunn E, Sigurdsson, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7061679/
https://www.ncbi.nlm.nih.gov/pubmed/32175521
http://dx.doi.org/10.1093/jncics/pkz100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7061679/
https://www.ncbi.nlm.nih.gov/pubmed/32175521
http://dx.doi.org/10.1093/jncics/pkz100

Ejemplares similares